http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0878475-A3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 |
filingDate | 1998-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1998-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0878475-A3 |
titleOfInvention | 5-(4-Piperidinyl)dibenzothiazepine derivatives and 5-(4-piperidinyl)dibenzoxazepine derivatives, and antiarrhythmic agents |
abstract | An objective of the present invention is to provide ancompound that has antiarrhythmic activity. The presentninvention provides a compound of formula (I):n nwherein R 1 and R 2 each represent H, halogen or lower alkylnwhich may be substituted by halogen; A represents H, C3-6ncycloalkyl, phenyl which may be substituted by halogen,nnitro, or lower alkoxy, a 5-membered or 6-memberednheterocyclic ring which may contain N and/or S, -NR 3 R 4 n(wherein R 3 and R 4 each represent H or lower alkyl which maynbe substituted by phenyl), or COR 5 (wherein R 5 representsnOH, amino or lower alkoxy); Q represents S or O; mnrepresents 0-18; and n represents 0-2, and pharmaceuticallynacceptable salts and solvates thereof. |
priorityDate | 1997-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.